Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Inflammation 2Frailty 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Prostatic Neoplasms 1Papillomavirus Infections 1Liver Neoplasms 1Liver Cirrhosis 1Leiomyoma 1Esophageal Neoplasms 1Deglutition Disorders 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

tremelimumab 1fluoromisonidazole 1epigallocatechin gallate 1durvalumab 1Ultrasonography 1Tomography, X-Ray Computed 1Tomography 1Positron-Emission Tomography 1Everolimus 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Liver Cirrhosis × epigallocatechin gallate × Clear all
NCT06015022 2025-09-05

CATCH-B

University of Texas Southwestern Medical Center

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡